Navigation Links
Pazopanib Shows Positive in Advanced Renal Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma

se. Currently there is no standard treatment for such patients. Of 80 patients included in the first stage of this study, 27 (34%) achieved progression-free survival at 12 weeks.

Pazopanib was evaluated in four types of STS in the first stage of the study: leiomyosarcoma, liposarcoma, synovial sarcoma and other soft tissue sarcomas. Pazopanib demonstrated activity in all tumor types except liposarcoma, and the study is ongoing to further investigate activity in the responsive tumor types. The most common AEs recorded were hypertension, fatigue, hair color change, and nausea. Please see safety considerations below.

About pazopanib. Pazopanib is an investigational, oral angiogenesis inhibitor targeting vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR), and c-kit. Pazopanib is currently in Phase III development for the treatment of advanced or metastatic RCC, after completing patient enrollment several months ahead of schedule, and is also being studied in a number of other trials across various tumor types.


'"/>




Page: 1 2 3 4

Related medicine news :

1. Experimental treatment for Ebola Virus Shows promising results in mice
2. New Prostate Cancer Vaccine Shows Promise
3. Ebola Treatment Shows Promise
4. New Drug Shows Significant Improvement In HIV-related Heart Condition
5. Greek Study Shows Living In The Hills May Be Healthier
6. Research Shows Carbon Monoxide Prevents Inflammations
7. Latest Research Shows That Multivitamins Might Not Prevent Infections In All Elderly
8. Novartis MS Drug Shows Promising Results
9. MRI Shows Emotional Changes During Menstrual Cycle
10. Bronchiolo-alveolar Carcinoma Shows Sonographic Pattern Of Pneumonia
11. AIDS drug GS 9137 Shows Promise
Post Your Comments:
(Date:12/2/2008)... The Health Story Project was anno...formerly known as “Clinical Document Archite...CDA4CDT will continue as the label for the technic...d to Health Level Seven (HL7) for ballot. The new ...Wire EON) December 2, 2008 -- "Our group has...
(Date:12/2/2008)...OR, Mich.---Older people tend to feel about 13 yea...is one of the findings of a study forthcoming in t... . The researchers analyzed the responses of 516 m...the Berlin Aging Study, tracking how their percept...hanged over a six-year period. , "People general...
(Date:12/2/2008)...elease is available in French . , Deep venous... the lower limbs, is the third-most common vascula...stroke, and is a frequent complication in hospital...ion that can lead to rapid death from pulmonary em... health concern that the U.S. Surgeon General and ...
(Date:12/2/2008)... WASHINGTON, Dec. 2 ...l deliver the Keynote address at eHealth Initiativ... the Pulse of Health IT: A Critical Review of Prog...ons for 2009 and Beyond." , , (Logo: http:..., , The Keynote speech will begin at 4:30 p...
Breaking Medicine News(10 mins):Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 2Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 4Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 5Health News:Old as you want to be: Study finds most seniors feel younger 2Health News:Thrombosis patients face greater risks than previously believed 2
... which is causing confusion among scientists, //...the scientist work overtime to decipher the reason...ive, queen bee, food and the young. Many years ag... leave the hive to be ransacked by honey bees from...
...could not seem to keep up with the other children ...hings compared to the other children. Her running ...ses it was found that she has CMT, Charcot-Marie-T...nd that her father and her brother Tony too suffer...
... tract infection. Wan et al reviewed //the clinica... and treatment. This study is important since urin...es of unexplained fevers in infants with an overal... 10%. All the patients in this study underwent ren...
...s interfere with the therapeutic effects of chemot...review of the use of antioxidants during chemother...s, tumor response, and the patient’s ability to to...mplications for patients whose oncologists discour...
Other Medicine News:Health News:Vanishing Honey Bees 2Health News:Cure for CMT 2Health News:Antioxidants May Aid Chemotherapy Patients 2
(Date:11/25/2008)... SUNNYVALE, Calif., Nov. 25 /PRNewswire-FirstCall...announced that the company has completed a Phase 1...el, first-in-class,small-molecule Factor VIIa inh...ealthy volunteers to evaluate the safety and pharm...tion of PCI-27483 resulted in a linear dose,respo...
(Date:11/25/2008)... LAS VEGAS, Nov. 25 Car...oard: CVBT), announced today that it has,dosed th...ts ACORD Phase II,clinical trial to treat patient...Angiogenesis for the treatment of CORonary heart D...e-blind, placebo-controlled doses in approximately...
(Date:11/24/2008)... ANN ARBOR, Mich., Nov. 24 Domino...der in pizza delivery, is gearing up to raise doug...spital during its fifth annual,Thanks and Giving ...nity to,make a donation at point of purchase to b... made when ordering over the phone or when orderin...
(Date:11/24/2008)... november is Pancreatic Cancer Awareness Month ,...wswire/ -- The American Society for Gastrointesti...ion Network are teaming up this November to raise ...nts about the disease and the resources that are a... the fourth leading cause of cancer deaths in the ...
Breaking Medicine Technology:Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 2ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 5ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 6Shanghai Medical Technology Co Ltd Completes Merger With Aamaxan Transport Group Inc 18271 1Shanghai Medical Technology Co Ltd Completes Merger With Aamaxan Transport Group Inc 18271 2Shanghai Medical Technology Co Ltd Completes Merger With Aamaxan Transport Group Inc 18271 3Shanghai Medical Technology Co Ltd Completes Merger With Aamaxan Transport Group Inc 18271 4GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals 5070 1GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals 5070 2GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals 5070 3Got Fat 3F 3A Plastic Surgeons Review Fat Melting and Fat Grafting Procedures 1960 1Got Fat 3F 3A Plastic Surgeons Review Fat Melting and Fat Grafting Procedures 1960 2Got Fat 3F 3A Plastic Surgeons Review Fat Melting and Fat Grafting Procedures 1960 3Bees disease 1 step closer to finding a cure 3160 1Bees disease 1 step closer to finding a cure 3160 2
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products: